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Impaired agonist-induced calcium signaling in hepatocytes from
chronic renal failure rats. Some hormones exert their action by inducing
a rise in cytosolic calcium [Ca2Ii (calcium signal), and therefore, a
blunting in hormone-induced calcium signal would engender resistance to
the action of the hormone. Chronic renal failure (CRF) is associated with
resistance to the action of a variety of hormones, a rise in [Ca21i and
decrease in the amount of mRNA of one hormone receptor, the PTH-
PTHrP receptor. We examined the calcium-signal induced by PTH,
angiotensin II, vasopressin and glucagon in hepatocytes from CRF
animals, evaluated the effect of the basal level [Ca2]i on the calcium
signal and explored the effect of [Ca2]i on the mRNA of the receptors of
these agonists. Hepatocytes from CRF rats have elevated basal levels of
[Ca2]i and display significantly reduced calcium signals induced by all
these hormones, while the calcium signals were normal in PTX-CRF
animals and those treated with verapamil both of which have normal levels
of [Ca2Ji despite CRF. The calcium signals induced by dibutyryl cyclic
AMP and G protein activator (GTPyS) were normal in hepatocytes from
CRF animals despite the high levels of [Ca2]i. Northern blotting
experiments revealed that the levels of the mRNA of the receptors of
PTH-PTHrP, angiotensin II and vasopressin were significantly reduced in
hepatocytes from CRF animals but PTX-CRF rats and those treated with
verapamil had either significantly greater or even normal amounts of the
mRNA of these receptors. The results show that: (1) in CRF there is a
reduction in the levels of the mRNA of hormone receptors which would
likely lead to decreased production of the receptors protein, that is,
down-regulation of receptors; (2) the elevation in [Ca2Ii in CRF plays an
important role in this phenomenon; (3) the hepatocyte G protein-
adenylate cyclase-cAMP pathway, which is important in mediating the
calcium signals of many hormones, is not impaired in CRF; and (4) the
reduction in the calcium signal induced by hormones is most likely due to
down-regulation of the hormone receptors and may not be affected by the
levels of [Ca2]i per se.
Resistance to the calcemic and phosphaturic action of parathy-
roid hormone (PTH) is common in chronic renal failure [1]. This
has been attributed to down-regulation and/or desensitization of
the PT}-I receptors secondary to the chronic elevation in the blood
levels of PTH in CRF [21. With the cloning of the PTH-PTHrP
receptor, it became possible to demonstrate that CRF is associ-
ated with decreased levels of the mRNA of this receptor in kidney
[3, 4], liver [4] and heart [5]. This observation is consistent with the
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notion that the synthesis of the PTH-PTHrP receptor is reduced
in CRF.
CRF has also been associated with a resistance to the actions of
other hormones such as insulin [6] and insulin-like growth factor
I [7]. Further, in CRF there is a reduction in the calcium
signal-induced by other agonists [8, 9] and hence reduced physi-
ological responses to the agonists. For example, glucose-induced
rise in cytosolic calcium ([Ca2]i) in pancreatic islets from CRF
animals is reduced [8] and glucose-induced insulin secretion by
these islets is impaired [10]. Since islets from CRF rats have high
basal levels of [Ca2]i [10], it was proposed that this elevation in
[Ca2]i interferes with the magnitude of the calcium signal
induced by glucose. Support for this proposition was provided by
the observation that islets from parathyroidectomized (PTX)-
CRF rats or CRF rats treated with verapamil which have normal
[Ca2]i displayed normal glucose-induced calcium signal [8] and
normal insulin secretion despite CRF [10, 11].
Recent data have shown that an elevation in [Ca2]i in kidney
[4], and heart [5] is a cellular derangement which is responsible, in
major part, for the down-regulation of the mRNA of the PTH-
PTHrP receptor. This interaction between [Ca2]i and the mo-
lecular machinery of the PTH-PTHrP receptor appears to be an
adaptive and protective phenomenon against continued deleteri-
ous effects of PTH on cell function. Since PTH causes a rise in
[Ca2]i of many cells in CRF [12] and since the elevation in
{Ca2Ji is a major contributor to cell dysfunction in CRF [12], it
is plausible that the rise in [Ca2]i provides a negative feedback
control mechanism through which the mRNA of the PTH-PTHrP
receptor is down-regulated, so that the increment in [Ca2]i of
cells does not progress unabated as the blood levels of PTH
continue to rise with progression of CRF.
These observations raise the interesting and fundamental ques-
tion of whether a rise in {Ca2]i in CRF also interferes with the
molecular machinery for the synthesis of receptors of agonists
other than the PTH-PTHrP. If so, then such a phenomenon may
provide the molecular basis for understanding the resistance to
other hormonal actions in CRF.
CRF is associated with a rise in [Ca2]i of hepatocytes [13]. We
therefore used these cells as a model system to examine the
magnitude of the calcium signal induced by several hormones, to
evaluate the effect of basal levels of [Ca2 F] on the calcium signal
and to explore the effect of [Ca2]i on the mRNA of the receptors
of these agonists.
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Methods
Male Sprague-Dawley rats weighing 250 to 380 g were used.
They were fed normal rat chow diet (Wayne Research Animal
Diets, Chicago, IL, USA), and they were allowed to drink water
ad libitum. The diet contained 1.4% calcium, 0.97% phosphorus,
and 4.4 IU of vitamin Dig. Studies were performed in five groups
of animals: (1) normal rats, (2) rats with CRF of six weeks
duration, (3) normocalcemic parathyroidectomized CRF rats
(CRF-PTX) of six weeks duration, (4) CRF rats of six weeks
duration treated with verapamil (0.1 .tg/g body wt) which was
given subcutaneously twice a day from day one of CRF (CRF-V),
and (5) normal rats treated with verapamil as described above for
six weeks (normal-V). CRF was produced by 5/6 nephrectomy.
The animals underwent right 2/3 nephrectomy through a flank
incision and a week later, a left nephrectomy was done. PTX was
performed by electrocautery, and the success of the procedure
was ascertained by a decrease in plasma levels of calcium of at
least 2 mg/dl. The PTX rats were allowed to freely drink water
containing 5% calcium gluconate. This procedure is adequate to
normalize plasma calcium in the PTX rats. Seven days after PTX,
the rats were subjected to 5/6 nephrectomy as described above.
Two days before sacrifice, the animals were housed in metabolic
cages and two consecutive 24-hour urine collections were ob-
tained for the measurement of creatinine clearance. The animals
were killed by decapitation on day 42 after the completion of the
5/6 nephrectomy in CRF rats (CRF, CRF-PTX, CRF-V) or after
the beginning of the treatment with verapamil in normal rats.
Hepatocytes were isolated using a modification of the method
of Seglen [14]. The animals were injected with 5,000 U of sodium
heparin (ICN Biochemical, Irvine, CA, USA), and 15 minutes
later the rats were sacrificed by decapitation. The chest was
opened and the aorta was cut and catheterized. Subsequently, the
liver was perfused with 200 ml cold (4°C) oxygenated calcium-free
Joklik media (Sigma Chemical Co., St. Louis, MO, USA) supple-
mented with 10 m Na HEPES, 10 m glucose, 0.5% BSA and 1
mM EGTA (pH, 7.4) over two minutes. At the end of this
procedure the liver was uniformly pale. Both superior and inferior
vena cava were ligated and a PE 20 tube was placed in the
superior vena cava below the ligation. The liver was then removed
and perfused through the vena cava catheter with warm (37°C)
oxygenated calcium-free Joklik medium with no EGTA but
containing 150 U collagenase type Il/mi (Worthington Biochem-
ical, Freehold, NJ, USA) and 0.6 mg hyaluronidase/ml (Sigma; pH
7.4) for 15 minutes with a flow of 15 ml/min. At the end of the
perfusion, the capsule of the liver was removed, and the liver was
teased gently and cut into small pieces by a scissor. The liver
fragments were placed on 250 .tm mesh nitex screen (Tetko,
Elmsford, NY, USA) and washed with 10 to 15 ml of oxygenated
and calcium-free Joklik medium without EGTA (pH 7.4). Hepa-
tocytes that filtered through the mesh nitex screen were collected.
The bigger liver fragments were placed into Joklik medium
containing collagenase and hyaluronidase for 15 minutes and
again filtered through the mesh nitex screen. The cell mixture was
centrifuged at 100 g for three minutes. The pellet was resus-
pended into 50 ml of calcium-free Joklik medium and refiltered
through the mesh nitex screen. The hepatocytes in the filtrate
were counted under the microscope. The cells of both normal or
CRF rats displayed a well preserved refringent shape as described
by Seglen [14], and by us [15]. Viability of cells was > 90% as
assessed by the trypan blue exclusion test. The hepatocytes were
then kept on ice for further studies.
Measurements of [Ca2]i of hepatocytes were made with Fura
2-AM (Sigma). The details of this method was reported from our
laboratory [15]. Calculation of [Ca2]i was made using the
Grynkiewicz et al equation [16]. The dissociation constant for
[Ca2Ji-Fura was assumed to be 225 nM [16]. The basal levels of
[Ca2]i of the hepatocytes are stable over a prolonged period of
time. Indeed, the values in hepatocytes kept on ice at zero time
and after 30, 60 and 90 minutes were not different. Furthermore,
the fluorescence of Fura-loaded hepatocytes and the ratio at
wavelengths 340 and 380 nm were followed for 30 minutes and
remained unchanged during this period of time. These observa-
tions indicate that the hepatocytes are intact and not leaky.
Basal levels of [Ca2]i of hepatocytes as well as the calcium
signal ( [Ca2]i) induced by both PTH-[1—34] and PTH-[l—84],
dibutyryl cAMP, guanosine 5 to 0 (3-triphosphate) (GTPyS),
vasopressin, angiotensin II and glucagon were measured in the
five groups of rats.
Total RNA was isolated from the liver by acid guanidinium
thiocyanate-phenol-chloroform extraction described by Chomc-
zynski and Sacchi [17] and later modified by Chomczynski [181
using Trizol reagent. The yields of total RNA (mgig tissue) from
the liver of the various groups of animal were not significantly
different (normal, 7.7 0.05; CRF, 6.7 0.74; CRF-PTX, 7.4
0.25; CRF-V, 7.5 0.46; normal-V, 7.6 0.81).
The poly A RNA of the liver was prepared from the total RNA
according to the method of Ansubel et al [19] as previously
described [4]. The yield of poly ARNA from total RNA was 3.7
0.37% in normal rats, 3.6 0.25% in CRF animals, 2.8
0.48% in CRF-PTX rats, 2.6 0.26% in CRF-V and 2.8 0.42%
in normal-V rats. These values were not statistically different.
R15B plasmid encoding the full length rat PTH-PTHrP recep-
tor was supplied by Dr. Geno V. Segre (Massachusetts General
Hospital, Boston, MA, USA). Plasmid DNA cloned in and
recovered from competent MC l061/P3 cells (In vitrogen Corp.,
San Diego, CA, USA), was digested with the restriction endonu-
clease Hindlil, and 1200-bp fragment of the cDNA PTH-PTHrP
receptor was recovered by gel electrophoresis as described previ-
ously [20, 21].
pCDM8 plasmid encoding rat angiotensin II (Ang II) receptor
(pCai8b) as described by Murphy et al [22] was supplied by Dr.
Kenneth E. Bernstein (Emory University, School of Medicine,
Atlanta, GA, USA). The plasmid was cloned into competent
MC1O61/P3 cells (In Vitrogen Corp.) in LB medium containing
tetracycline and ampicillin. The isolated plasmid DNA was di-
gested with the restriction endonuclease HindilI, and the 2200 bp
fragment of the cDNA of Ang II receptor was recovered by gel
electrophoresis.
SP6T7PcD plasmid encoding the rat vasopressin la (Via)
receptor cDNA (15a-36) as described by Morel et al [23] was
supplied by Dr. Stephen J. Lolait (National Institute of Health,
Bethesda, MD, USA). The plasmid was cloned into E. coli DHScx
(Life Technologies, Gaithersburg, MD, USA) in LB medium
containing ampicillin. Plasmid DNA was digested with the restric-
tion endonuclease Kpnl and PvuII, and 395 bp fragment of the
cDNA of Via receptor was recovered.
An aliquot containing 30 ng of the fragment of the cDNA of the
PTH-PTHrP, Ang II or Via receptors were labeled with 5 l of
32p dCTP (10 mCi/mi; Amersham, Arlington Height, IL, USA)
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N g Creatinine Calcium Phosphorus
Normal 16 345 6.5 (133 0.02 9.8 0.20 6.7 0.20 18 2.05 538 25
CRF 14 340 7.2 1.05 0.02 9.9 0.18 6.8 0.20 67 6.2a 160 6.9a
CRF-PTX 12 348 8.3 0.98 0.03 9.3 0.20 6.3 0.15 16 4.2 178 7,5a
CRF-V 14 350 7.5 1.05 0.03° 9.9 0.18 6.8 0.20 67 6.2a 160 6.9°
Normal-V 13 370 6.2 0.31 0.02 9.5 0.15 6.6 0.26 17 3.3 520 22.5
Data are presented as mean I SE,
ap < 0.01 versus other groups by one way analysis of variance (ANOVA)
using a Random Primed DNA Labeling Kit (Boehringer-Manne-
heim, Indianapolis, IN, USA) and purified through G50 Sepha-
rose (Sigma Chemical Co.).
Aliquots of 4 .tg of poly ARNA of the liver were placed in
separate lanes of 1.2% agarose-formaldehyde gel and subjected to
electrophoresis in 1XMOPS buffer (20 mrvi MOPS, 5 m sodium
acetate and 10 mr'i EDTA, p1-I 7.4) at 100 volts for three hours.
The separated poiy ARNAs were transferred to Hybond N
nylon paper (Arnersham) with 20 x SSC (1.5 M NaC1 and 0.15 M
sodium citrate, pH 7.5). The poly A RNA was cross-linked to the
membrane in a UV Strata Linker 1800 (Stratagene, La Jolla, CA,
USA).
Prehybridization of the membrane was performed in 7% SDS,
1% polyethylene glycol, 2 X SSPE (0.9 M NaCI, 40 m'vi NaOH, 50
mM NaH2PO and 5 mM EDTA, pH 7.4) for two hours at 68°C
[21]. Subsequently, the membrane was hybridized for 16 hours at
68°C with 10 ml of prehybridization solution plus the 32P-labeled
eDNA probes of the PTH-PTHrP, Ang II, and Via receptors
(specific activity 106 cpm/ml). The membrane was washed twice
(20 mm at 65°C) with 1% SDS, 50 mrvi NaC1 and 12 mtvi EDTA.
The membrane was then autoradiographed and analyzed by
densitometric scanning (LKB Ultroscan IX, Bromma, Sweden).
Northern blot analysis from the same poly ARNA were per-
formed using cDNA probe of G3PDH, (Clontech Lab. Inc. Palo
Alto, CA, USA). The amount of mRNA of the PTH-PTHrP, AT1
and Via receptor in the liver from animals with the various
experimental conditions were normalized by calculating the ratio
between the mRNA of the receptor and the G3PDH in the same
tissue.
The measurement of calcium in plasma was made by Perkin
Elmer atomic absorption spectrophotometer, model 503, (Perkin
Elmer Corp, Norwalk, CT, USA) and those of plasma creatinine
and phosphorus and urine creatinine by an autoanalyzer (Tech-
nicon Instrument Corp., Tarrytown, NY, USA). The serum levels
of PTH were determined by an ISN-PTH immunoassay kit
(Nichols Institute Diagnostics, San Juan Capistrano, CA, USA),
This assay recognizes the aminoterminal fragment of PTH. The
lowest detectable level is 3 pg/mI; the intra-assay variation is 7.3%
and the interassay variation is 4%.
Bovine PTH-[i—84] (lot i0H06661) vasopressin, angiotensin II
and glucagon were purchased from Sigma, and bovine synthetic
PTH-[1—34] was obtained from Bachem (Torrance, CA). Dibu-
tyryl cAMP and guanosine 5—0-(3-triphosphate) (GTPyS) were
purchased from Sigma. Bovine (PTH-[1—841 was dissolved in 0.15
N acetic acid and synthetic bovine PTH-[1—34j, GTPyS, vasopres-
sin, angiotensin II and glucagon in water. Dibutyryl cAMP was
dissolved in dimethyl sulfoxide (DMSO).
Statistical analysis utilized paired or unpaired (-test. Compari-
son between groups was assessed by one way analysis of variance
PTH-(l-34
N Basal
[Ca2]i nM
) 10 M PTH-(1-84) 10 M
z Basal
227 4.2 171 1306
278 73° 58 69a.b
216 6.7 174 10.96
210 2.7 65 44a,h
215 3.3 165 756
Normal 11 215 5.4 113 7.8
CRF 9 273 7.6° 34 3,9a
CRF-PTX 8 210 7.1 97 7.3
CRF-V 9 212 5.6 25 2.o
Normal-V 10 211 3.2 107 6.3
The concentration of 106 M PTH was chosen based on previous
observations showing that this concentration of PTH produced maximal
effect on [Ca2]i of hepatocytes [15]. Data are presented as mean 1 SE.
a P < 0.01 versus other groups by one way analysis of variance
(ANOVA)6 P < 0.01 versus PTH-(1-34) by one way analysis of variance (ANOVA)
(ANOVA) and significane was determined with Bonnferroni-
Dunn test.
Results
Table 1 shows the body weights and the biochemical parameters
of the five groups of animals studied. The body weights among
normal, CRF, CRF-PTX, CRF-V and normal-V rats were not
different. There were no significant differences between the
concentrations of calcium and phosphorus in plasma. The 5/6
nephrectomy resulted in significant increments (P < 0.01) in the
plasma concentrations of creatinine and significant decrements in
the values of creatinine clearance. The values of these two
parameters were not different among the CRF, CRF-PTX and
CRF-V rats. The serum levels of PTH were significantly (P <
0.01) elevated in CRF and CRF-V rats as compared to those in
CRF-PTX, normal and normal-V rats, and the values in these
latter three groups of animals were not different.
As we reported before [131, the basal levels of [Ca2]i in
hepatocytes of CRF rats were significantly (P < 0.01) higher than
in normal animals (Table 2). This elevation in basal levels of
[Ca2Ji was prevented either by PTX of CRF rats or by their
treatment with verapamil. To determine whether CRF blunted
the effects of PTH on the hormone-dependent increment of
[Ca2]i, we exposed hepatocytes to 10—6 M concentrations of
PTH-[1—84} and PTH-[1—34]. Both moieties of PTH produced
significant (P < 0.01) increments in [Ca2ji of hepatocytes from
all five group of animals, but the magnitude of the PTH-induced
rise in [Ca2]i in CRF and CRF-V rats was significantly (P < 0,01)
smaller than in normal, CRF-PTX, and normal-V animals. The
PTH-induced calcium signals in the latter three group of rats were
not different. In all these studies the effects of PTH-[1--84] was
Table 1. Body weight and biochemical parameters of all the groups of animals studied
Body Plasma mg/dl
weight
Serum
PTH
pg/mi
Creatinine
clearance
jjJ/min/100 g
Table 2. Basal levels of [Ca21i of hepatocytes and the effects of PTH-
(1-84) and PTH-(1-34) on their [Ca2Ji
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Table 3. Basal levels of [Ca2]i of hepatocytes and the effect of
dibutyryl cAMP or GTPyS on their [Ca24 Ii
Dibutyryl cA
N Basal
[Ca2ji nM
MP 400 rM GTPyS 100 yrvi
Basal
Normal 8 199 5.9 225 14.4 202 5.2 221 2.2
CRF 8 285 12.2a 209 16.4 275 7.1 219 11.9
CRF-PTX 8 208 2.4 185 16.5 210 4.4 207 15.3
CRF-V 6 210 4.6 197 20.8 211 4.6 209 16.4
Normal-V 9 216 2.2 209 7.8 213 2.8 229 11.1
The concentrations of dibutyryl cyclic AMP and GTPyS were chosen
based on previous observation that these concentrations produced maxi-
mal effects on [Ca2]i of hepatocytes [151. Data are presented as mean
1 SE.
P < 0.01 versus all groups by one way analysis of variance (ANOVA)
significantly greater (P < 0.01) that those of equimolar quantities
of PTH-[1—34].
Since PTH-induced rise in [Ca2]i in hepatocytes is mediated
by a receptor-activated G protein adenylate cyclase-cyclic AMP
systems [15], we next asked whether blunted PTH response was
due to a block in those second messengers. Accordingly we
exposed hepatocytes to a G protein activator (GTPyS) and to
dibutyryl cAMP. Table 3 contains the data on the effect of 400 .tM
dibutyryl cAMP and of 100 I.tM GTPYS on [Ca2]i of hepatocytes
from the five groups of rats. Although the basal levels of [Ca2]i
of the hepatocytes from CRF rats were elevated, the dibutyryl
cAMP- and the GTPyS-induced increments in [Ca2]i were not
different from those in hepatocytes of CRF-PTX, CRF-V, nor-
mal-V and normal rats. We conclude that the messenger systems
are not impaired in CRF and that the blunted PTH action is due
to impaired levels of receptor activity.
Table 4 depicts the effects of 10 nM vasopressin, 50 nM
angiotensin II and 10 nM glucagon on the [Ca2]i of hepatocytes
from the five groups of rats. The increment in [Ca2]i induced by
these agonists in hepatocytes from CRF rats was significantly (P <
0.01) lower than those in normal, CRF-PTX, CRF-V and nor-
mal-V animals, and the values among the latter four groups of rats
were not different. Since these hormones also function through
G-protein activated signals transduction, we conclude that in CRF
their actions are also blunted by events that impair activation
levels of their receptors.
We and others had previously found that the PTH-PTHrP
receptor mRNA levels are reduced in kidney [3, 4] and heart [5]
in CRF. To evaluate receptor mRNA levels in hepatocytes
Northern blot analysis was used with probes specific for PTH-
PTHrP, Ang II and Via receptor RNAs. The autoradiographic
signals were compared with signals from the mRNA for G3PDH,
a housekeeping enzyme whose concentration is relatively stable in
a variety of circumstances. Since the total amount of poly AERNA
loaded in each lane of the gels used for Northern blotting were
constant, the ratio of the signals from receptor mRNA of the
hormones to G3PDH mRNA provides a relative index of the
levels of receptor mRNA of the various hormones in normal
hepatocytes versus the hepatocytes in the other four groups of
rats.
Figure 1 depicts autoradiographs of Northern blots of the
mRNA of the PTH-PTHrP receptor and of G3PDH in liver cells
of normal, CRF, CRF-PTX, CRF-V and normal-V rats. The
expression of the mRNA of the PTH-PTHrP receptor in liver cells
of CRF rats is reduced in comparison to that of the other groups
of animals. The relative concentrations of the mRNA of this
receptor to that of the G3PDH in the liver of CRF rats (2.9
0.6%) was significantly (P < 0.05) lower than that of normal rats
(7.2 0.9%) and of CRF-PTX animals (5.5 0.6%). The
treatment of the CRF animals with verapamil was associated with
an increase in the mRNA concentration of the PTH-PTHrP
receptor, with the relative value to that of G3PDH being 4.6
0.2%. Although the values in CRF-PTX and CRF-V rats were
significantly higher than in CRF animals, they still were lower
than those in normal rats (P < 0.05). In normal-V animals, the
value was 7.8 0.7%, and it was not different from normal rats.
The results of similar experiments assaying Ang II rnRNA are
shown in Figure 2. The expression of mRNA of this receptor was
significantly reduced in CRF rats in comparison to the other
groups. The relative concentration of the mRNA of the Ang II
receptor to the housekeeping gene was 12 1.6% in CRF rats
compared to 81 5.5% in normal animal and 32 4.4 in
CRF-PTX rats. The values of the latter group of animals were still
lower (P < 0.01) than that of normal. Treatment of the CRF
animals with verapamil produced complete correction of the
expression of the mRNA of this receptor.
Figure 3 shows the autoradiographs of the mRNA of the Via
receptor. In CRF animals, there was a significant reduction in the
expression of the mRNA of this receptor. Both PTX of the CRF
rats or their treatment with verapamil corrected this abnormality.
Indeed, the relative ratio of mRNA of the receptor and that of the
housekeeping gene in the CRF rats (3.8 1.5%) was significantly
(P < 0.01) lower than that in normal animals (42 7.5%) and in
CRF-PTX rats (25 2.5%). The values in the latter two groups
were not different. Treatment of CRF rats with verapamil pre-
vented the decrease in the expression of the mRNA of the Via
receptor.
Discussion
The results of the present study demonstrate that the basal
levels of [Ca2]i of hepatocytes in CRF are elevated and that the
calcium signal induced by many agonists including PTH, vasopres-
sin, angiotensin and glucagon is significantly reduced. This phe-
nomenon may not be limited to the hepatocytes. Indeed, the basal
levels of [Ca2]i in the pancreatic islets of animals with CRF are
elevated [10] and the glucose-induced calcium signal in these cells
is reduced [8]. Further, polymorphonuclear leukocytes from hu-
mans [24] and animals [25] display elevated basal levels of [Ca2]i
and the calcium signal in response to monoclonal antibody 3G8,
with the specificity anti-CD16 reacting with FcyRIII receptor, is
reduced [24]. Since [Ca2]i is elevated in many other cells in CRF
[12], it is reasonable to propose that there would be a reduction in
agonist-induced calcium signal in such cells and hence a reduced
physiological response to various agonists.
The calcium signal induced by many hormones requires an
interaction between the agonist and its receptor, a normal amount
and affinity of the receptor, and the activation of post-receptor
pathways that either permit calcium influx and/or mobilize cal-
cium from intracellular stores. One or more of these steps may be
impaired in CRF and contribute to the defective calcium signal. It
is also possible that the elevation in basal levels of [Ca2]i of cells
per se may limit the magnitude of calcium signals, if the cell has a
ceiling in [Ca2]i that cannot be exceeded. Our results shed lights
on these theoretical considerations and provide insights into the
mechanism(s) responsible for impairment in the agonist-induced
calcium signal in CRF.
We have previously shown that PTH increases [Ca2]i of
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Table 4. Basal levels of [Ca2]i of hepatocytes and the effect of vasopressin, angiotensin II and glucagon on their [Ca2Ii
N
[Ca2]i nM
Vasopres
Basal
sin 10 nM
z
Angiotensin II 50 nM Glucagon 10 nM
Basal Basal
Normal
CRF
CRF-PTX
CRF-V
Normal-V
8
9
8
9
10
222 3.3
281 74a
212 1.1
209 5.1
215 2.3
243 10.0
99 59a
222 12.1
216 12.1
233 9.0
208 4.7
257 4.0
210 1.4
208 1.5
208 3.1
233 22.3
172 49a
230 14.3
229 21
244 25.9
218 4.3
258 4.2a
205 2.4
212 5.9
206 5.6
79 5.353 1.p
69 3.6
75 5.3
84 6.4
The concentrations of vasopressin, angiotensin II and glucagon were chosen based on preliminaiy observations showing that these concentrations
produced maximal effects on [Ca2]i of hepatocytes. Data presented as mean 1 SE.
a p < 0.01 versus other groups by one way analysis of variance (ANOVA)
Fig. 1. Northern blot analysis of mRJ'JA of PTH-PTHrP receptor and G3PDH of liver from normal, CRF, CRF-PTX, CRF-VER (CRF-verapamil) and
normal-VER (normal-verapamil) rats. Each lane contains 4 g of poly ARNA from different animals. The hybridizations of the membranes containing
the poly ARNA of liver with PTH-PTHrP receptor probe and with the G3PDH probe were done separately because the sizes of their mRNA are very
close. However, studies from all animals were done at the same time and under the same conditions. The exposure time of the autoradiographs was
96 hours. The autoradiographs were scanned as described in the Methods section. The numbers provide the mean 1 SE of the density of the mRNA
signal of the receptor relative to that of G3PDH. The values in CRF rats is significantly (P < 0.05) lower than those in normal, CRF-PTX, CRF-VER
and normal-VER. The value in CRF-PTX is not different from normal. The value in CRF-VER is lower (P < 0.05) than in normal-VER.
hepatocyte with the effect of PTH-[l--84] being greater than that
of equimolar quantity of PTH-[1—34]. This action of PTH is a
receptor-mediated process; the predominant pathway for the
effects of the hormone is stimulation of a G protein-adenylate
cyclase-cAMP system which then leads to activation of a calcium
transport system inhibitable by verapamil; the PTH-induced cal-
cium signal is mainly due to an increase in calcium influx [15].
Several findings in our study indicate that the mechanism respon-
sible for the reduced calcium signal in response to PTH in
hepatocytes from CRF rats may be due to decreased production
and consequently decreased levels of the PTH receptor. First, the
concentration of mRNA of the PTH-PTHrP receptor is signifi-
cantly reduced in these cells. This decrease in mRNA amount
would presumably result in decreased synthesis of the receptor
protein and hence reduced action of the hormone. Second, both
the G protein activator (GTP'yS) and dibutyryl cAMP produced
normal calcium signal in these hepatocytes, indicating that the
post-receptor pathways utilized by PTH to increase [Ca2 Ii in
hepatocytes are not impaired. Third, the finding that the calcium
signal induced by dibutyryl cAMP and GTPyS in CRF are normal
in CRF despite high [Ca2]i of the cells, and the observation that
the PTH-induced calcium signal in hepatocytes of CRF-V animals
CRF-PTX
PTH-PTHrP
receptor
G3PDH
NORMAL
PTH-PTHrP /G3PDH
Ratio
PTH-PTHrP /G3PDH
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Fig. 2. Northern blot analysis of the mRNA of the Ang II receptor and G3PDJ-I of liver of normal, CRF, CRF-PTX, CRF-V and normal-V rats. Each lane
contains 4 jrg of poiy ARNA from different animals. The hybridization of the membrane containing poly ARNA of the liver with Ang H receptor
and G3PDH probes were done simultaneously for both studies shown in A and B. The exposure time of the autoradiographs was 24 hours. The
autoradiographs were scanned as described in the Methods section. The numbers provide the mean 1 SE of the density of the mRNA signal of the
receptor relative to that of G3PDH. The values in CRF is significantly (P < 0.01) lower than in normal or CRF-PTX rats. The latter value is significantly(P < 0.01) lower than in normal. The values in CRF-V rats are not different from those in normal and normal-V animals.
is reduced despite normal [Ca2}i, vitiate the idea that the
impaired signal is due to the high [Ca21i per se.
It should be mentioned that for the GTPyS to exert its action,
it must penetrate the hepatocytes. The permeability of hepato-
cytes for this agonist was not examined in the present study. We
have perviously shown that GTPyS produced a rise in [Ca2]i in
other cells such pancreatic islets [261, myocardial cells [271 and
adipocytes [281. These observations are consistent with the motion
that of GTPyS may enter these cells. If the GTPYS does not enter
the hepatocytes, it must exert its effect on hepatocyte mem-
brances. The nature of such potential interaction is not known.
Another finding regarding the interaction between hepatocytes
from CRF-V rats and PTH deserves a comment. In these animals
the mRNA of the PTH-PTHrP receptor is significantly higher
than that in CRF animals; therefore, one would expect that the
amount of the receptor protein is also greater and hence a better
or a normal PTH-induced calcium signal should be obtained.
However, the signal was still reduced and not different from that
in CRF rats. In the CRF-V rats, the blood levels of PTH are still
elevated and they are not different from those in CRF animals.
Therefore, one would expect that these high levels of PTH already
occupy many of the PTH receptor sites and hence the exposure of
the cells to more PTH may fail to produce a normal calcium
signal.
The concentrations of the mRNAs of the Via and Ang II
receptors were also reduced in hepatocytes from CRF rats, and
both PTX of these animals or their treatment with verapamil
either significantly increased or normalized the concentration of
the mRNA of these receptors despite CRF. It seems, therefore,
that the reduction in the calcium signal induced by these hor-
mones in hepatocytes of CRF rats, and the correction of the
signals in CRF-PTX and CRF-V animals are related to the
NORMAL
AT1 /G3PDH
ratio
CRF
70 7.0%
CRF-PTX
66 7.0%
AT1
receptor
G3PDH
AT1
receptor
G3PDH
cn cnn
Ct7S% 3lttfl
pIoAt v
AVP/G3PDH 69±6.8%
ratio
Fig. 3. Northern blot analysis of mRNA of Via (A VP) receptor and G3PDH of liver of no,mal, CRF, CRF-PTX, CRF-V and normal-V rats. Each lane
contains 4 pg of poiy ARNA from different animals. The hybridization of the membrane containing the poly ARNA of the liver with Via receptor
and G3PDH probes were done simultaneously for both studies shown in A and B. The exposure time of the autoradiographs was 24 hours. The
autoradiographs were scanned as described in the Methods section. The numbers provide the mean 1 SE of the density of the mRNA signal of the
receptor relative to that of G3PDH. The values in CRF is significantly (P < 0.01) lower than in normal and CRF-PTX rats. There were no significant
differences in the values among normal, CRF-V and normal-V rats.
changes in availability of the receptors in the various groups of
animals with CRF.
The reduced expression of the mRNA of the PTH-PTHrP, Via
and Ang II receptors in CRF appears to be influenced by the
elevation in the levels of [Ca2'Ji. Indeed, the prevention of the
rise in [Ca2]i in the hepatocytes of CRF animals by PTX or by
their treatment with verapamil normalized the [Ca2]i of the
hepatocytes and corrected the decrease in the expression of the
mRNA of these receptors. The observation of Yang and Tashjian
[29] supports this proposal. They found that an increase in [Ca2]i
decrease in the mRNA of another hormone receptor, thyroid
releasing hormone (TRH) receptor. It is, theorectically, possible
that verapamil may directly cause an increase in the mRNA of the
hormone receptors; this seems unlikely since treatment of normal
rats with verapamil did not affect the mRNA of these receptors.
It should be mentioned that Urena et al [30] reported in an
abstract form that they were unable to show that PTX of CRF rats
restored the concentration of the mRNA of the PTH-PTHrP
receptor in the kidneys of these animals. The reason for the
difference between their data and ours is not evident. We,
1330 Massry et al: Impaired calcium signals in CRF
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of GH4CI cells, induced by ionomycin, was associated with a however, have also found that PTX of CRF rats was associated
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with the return of the concentration of the mRNA of the
PTH-PTHrP receptor towards normal in the kidney [4] and heart
[5] of these animals.
The mechanisms through which an elevation in [Ca2]i inter-
feres with the molecular machineiy for the accumulation of these
peptide receptor mRNAs are not known. The increase in [Ca2]i
may impair the transcription or processing of the mRNA of these
receptors and/or increase turnover of the mRNA. The data of
Young and Tashjian [29] provided evidence that a rise in [Ca2]i
adversely affected the rate of gene transcription of TRH receptor
in the GH4C1 cells. Others have found that CRF is associated with
increased degradation of albumin mRNA in liver in CRF [31, 32].
Thus, either one or both mechanisms may be at work to explain
the reduction in the concentration of the mRNA of PTH-PTHrP,
Ang II and Via receptors in CRF.
Our data are consistent with the proposition that the PTH-
mediated rise in basal levels of [Ca2]i in CRF provides a negative
feedback mechanism through which the mRNA of the PTH-
PTHrP receptor is down-regulated to protect the cell against
continued increase in blood levels of PTH. However, this useful
adaptive process is not without adverse effects. The trade-off is
down-regulation of the mRNA of receptors of other hormones
resulting in resistance to the action such hormones.
Since our study measured mRNA levels, we can only infer that
receptor protein levels are reduced in parallel to account for the
blunted hormone responses. Direct confirmation of this hypoth-
esis must awaits analysis of receptor levels by hormone binding
assays or direct measurements of receptors protein.
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